The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Vidalta 15 mg prolonged-release tablets for cats

Intervet Ireland LimitedVPA10996/263/002

Main Information

Trade NameVidalta 15 mg prolonged-release tablets for cats
Active SubstancesCarbimazole
Dosage FormTablet
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/263/002

Group Information

ATC CodeQH03BB01 carbimazole
Therapeutic ClassHormone


License statusAuthorised
Licence Issued09/12/2011
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back